Grantham, Mayo, Van Otterloo & Co (GMO)’s Cal-Maine CALM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
18,780
+9,964
+113% +$769K ﹤0.01% 480
2026
Q1
$698K Sell
8,816
-939
-10% -$77.1K ﹤0.01% 536
2025
Q4
$776K Buy
9,755
+508
+5% +$44.6K ﹤0.01% 544
2025
Q3
$870K Buy
9,247
+2,366
+34% +$253K ﹤0.01% 493
2025
Q2
$686K Buy
6,881
+3,854
+127% +$368K ﹤0.01% 516
2025
Q1
$275K Buy
+3,027
New +$299K ﹤0.01% 576

Other funds holding CALM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CALM Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Cal-Maine (CALM) stake by 113% in Q2 2026, buying an estimated $769K and bringing the position to 18,780 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CALM in Q1 2025 and has held it in 6 quarters since. 456 funds tracked by Wall St. Rank hold CALM as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 18,780 shares of Cal-Maine worth $1.51M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 9,964 Cal-Maine shares in Q2 2026, an estimated $769K.
  • Cal-Maine made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #480 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cal-Maine in Q1 2025 and has held it in 6 quarters since.
  • 456 funds tracked by Wall St. Rank held Cal-Maine as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.